A novel histone H4 variant H4G regulates rDNA transcription in breast cancer

被引:51
作者
Long, Mengping [1 ]
Sun, Xulun [1 ]
Shi, Wenjin [1 ]
Yanru, An [1 ]
Leung, Sophia T. C. [1 ]
Ding, Dongbo [1 ]
Cheema, Manjinder S. [2 ]
MacPherson, Nicol [3 ]
Nelson, Christopher J. [2 ]
Ausio, Juan [2 ]
Yan, Yan [1 ]
Ishibashi, Toyotaka [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China
[2] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada
[3] BC Canc Vancouver Isl Ctr, Dept Med Oncol, Victoria, BC V8R 6V5, Canada
基金
加拿大健康研究院;
关键词
GENE-EXPRESSION; NUCLEOLAR PROTEIN; STRUCTURAL BASIS; CHAPERONE; DNA; MUTATIONS; H3; HETEROCHROMATIN; EPIGENETICS; MECHANISMS;
D O I
10.1093/nar/gkz547
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone variants, present in various cell types and tissues, are known to exhibit different functions. For example, histone H3.3 and H2A.Z are both involved in gene expression regulation, whereas H2A.X is a specific variant that responds to DNA double-strand breaks. In this study, we characterized H4G, a novel hominidae-specific histone H4 variant. We found that H4G is expressed in a variety of human cell lines and exhibit tumor-stage dependent overexpression in tissues from breast cancer patients. We found that H4G localized primarily to the nucleoli of the cell nucleus. This localization was controlled by the interaction of the alpha-helix 3 of the histone fold motif with a histone chaperone, nucleophosmin 1. In addition, we found that modulating H4G expression affects rRNA expression levels, protein synthesis rates and cell-cycle progression. Our data suggest that H4G expression alters nucleolar chromatin in a way that enhances rDNA transcription in breast cancer tissues.
引用
收藏
页码:8399 / 8409
页数:11
相关论文
共 66 条
  • [1] Identification and characterization of the Drosophila histone h4 replacement gene
    Akhmanova, A
    Miedema, K
    Hennig, W
    [J]. FEBS LETTERS, 1996, 388 (2-3): : 219 - 222
  • [2] Nucleolin is a histone chaperone with FACT-like activity and assists remodeling of nucleosomes
    Angelov, Dimitar
    Bondarenko, Vladimir A.
    Almagro, Sebastien
    Menoni, Herve
    Mongelard, Fabien
    Hans, Fabienne
    Mietton, Flore
    Studitsky, Vasily M.
    Hamiche, Ali
    Dimitrov, Stefan
    Bouvet, Philippe
    [J]. EMBO JOURNAL, 2006, 25 (08) : 1669 - 1679
  • [3] Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020
  • [4] Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells
    Baldan, Federica
    Mio, Catia
    Allegri, Lorenzo
    Conzatti, Ketty
    Toffoletto, Barbara
    Puppin, Cinzia
    Radovic, Slobodanka
    Vascotto, Carlo
    Russo, Diego
    Di Loreto, Carla
    Damante, Giuseppe
    [J]. ONCOTARGET, 2016, 7 (39) : 63388 - 63407
  • [5] Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors
    Bassing, CH
    Suh, H
    Ferguson, DO
    Chua, KF
    Manis, J
    Eckersdorff, M
    Gleason, M
    Bronson, R
    Lee, C
    Alt, FW
    [J]. CELL, 2003, 114 (03) : 359 - 370
  • [6] Resistance, epigenetics and the cancer ecosystem
    Baylin, Stephen B.
    [J]. NATURE MEDICINE, 2011, 17 (03) : 288 - 289
  • [7] Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
    Bender, Sebastian
    Tang, Yujie
    Lindroth, Anders M.
    Hovestadt, Volker
    Jones, David T. W.
    Kool, Marcel
    Zapatka, Marc
    Northcott, Paul A.
    Sturm, Dominik
    Wang, Wei
    Radlwimmer, Bernhard
    Hojfeldt, Jonas W.
    Truffaux, Nathalene
    Castel, David
    Schubert, Simone
    Ryzhova, Marina
    Seker-Cin, Huriye
    Gronych, Jan
    Johann, Pascal David
    Stark, Sebastian
    Meyer, Jochen
    Milde, Till
    Schuhmann, Martin
    Ebinger, Martin
    Monoranu, Camelia-Maria
    Ponnuswami, Anitha
    Chen, Spenser
    Jones, Chris
    Witt, Olaf
    Collins, V. Peter
    von Deimling, Andreas
    Jabado, Nada
    Puget, Stephanie
    Grill, Jacques
    Helin, Kristian
    Korshunov, Andrey
    Lichter, Peter
    Monje, Michelle
    Plass, Christoph
    Cho, Yoon-Jae
    Pfister, Stefan M.
    [J]. CANCER CELL, 2013, 24 (05) : 660 - 672
  • [8] Inhibiting eukaryotic transcription Which compound to choose? How to evaluate its activity?
    Bensaude, Olivier
    [J]. TRANSCRIPTION-AUSTIN, 2011, 2 (03): : 103 - 108
  • [9] Variants of core histones and their roles in cell fate decisions, development and cancer
    Buschbeck, Marcus
    Hake, Sandra B.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2017, 18 (05) : 299 - 314
  • [10] Genomic instability in mice lacking histone H2AX
    Celeste, A
    Petersen, S
    Romanienko, PJ
    Fernandez-Capetillo, O
    Chen, HT
    Sedelnikova, OA
    Reina-San-Martin, B
    Coppola, V
    Meffre, E
    Difilippantonio, MJ
    Redon, C
    Pilch, DR
    Olaru, A
    Eckhaus, M
    Camerini-Otero, RD
    Tessarollo, L
    Livak, F
    Manova, K
    Bonner, WM
    Nussenzweig, MC
    Nussenzweig, A
    [J]. SCIENCE, 2002, 296 (5569) : 922 - 927